Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 6;25(7):1345-1354.
doi: 10.1093/neuonc/noad009.

Hypothalamic-pituitary-gonadal function, pubertal development, and fertility outcomes in male and female medulloblastoma survivors: a single-center experience

Eve Stern  1   2 , Michal Ben-Ami  1   2 , Noah Gruber  1   2 , Amos Toren  2   3 , Shani Caspi  2   3 , Gadi Abebe-Campino  2   3 , Michal Lurye  3 , Michal Yalon  2   3 , Dalit Modan-Moses  1   2
Affiliations

Hypothalamic-pituitary-gonadal function, pubertal development, and fertility outcomes in male and female medulloblastoma survivors: a single-center experience

Eve Stern et al. Neuro Oncol. .

Abstract

Background: Endocrine deficiencies, including hypothalamic-pituitary-gonadal axis (HPGA) impairment, are common in survivors of childhood and adolescent medulloblastoma. Still, data regarding pubertal development and fecundity are limited, and few studies assessed HPGA function in males. We aimed to describe HPGA function in a large cohort of patients with medulloblastoma.

Methods: A retrospective study comprising all 62 medulloblastoma patients treated in our center between 1987 and 2021, who were at least 2 years from completion of therapy. HPGA function was assessed based on clinical data, biochemical markers, and questionnaires.

Results: Overall, 76% of female patients had clinical or biochemical evidence of HPGA dysfunction. Biochemical evidence of diminished ovarian reserve was seen in all prepubertal girls (n = 4). Among the males, 34% had clinical or biochemical evidence of gonadal dysfunction, 34% had normal function, and 29% were age-appropriately clinically and biochemically prepubertal. The difference between males and females was significant (P = .003). Cyclophosphamide-equivalent dose was significantly associated with HPGA function in females, but not in males. There was no association between HPGA dysfunction and other endocrine deficiencies, length of follow-up, weight status, and radiation treatment protocol. Two female and 2 male patients achieved successful pregnancies, resulting in 6 live births.

Conclusions: HPGA dysfunction is common after treatment for childhood medulloblastoma. This is seen more in females, likely due to damage to the ovaries from spinal radiotherapy. Our findings may assist in counseling patients and their families regarding risk to future fertility and need for fertility preservation.

Keywords: childhood cancer survivors; cyclophosphamide-equivalent dose; fertility; medulloblastoma; puberty.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1.
Figure 1.
Flow diagram for study participants.
Figure 2.
Figure 2.
HPGA function in male and female study participants.
See this image and copyright information in PMC

References

    1. Salloum R, Chen Y, Yasui Y, et al. Late morbidity and mortality among medulloblastoma survivors diagnosed across three decades: a report from the childhood cancer survivor study. Am J Clin Oncol. 2019; 37(9):731–740. - PMC - PubMed
    1. Venes JL, McIntosh S, O’Brien RT, Schwartz AD. Chemotherapy as an adjunct in the initial management of cerebellar medulloblastomas. A preliminary report. J Neurosurg. 1979; 50(6):721–724. - PubMed
    1. Gerosa MA, di Stefano E, Olivi A, Carteri A. Multidisciplinary treatment of medulloblastoma: a 5-year experience with the SIOP trial. Child’s Brain. 1981; 8(2):107–118. - PubMed
    1. Cuny A, Trivin C, Brailly-Tabard S, et al. Inhibin B and anti-Müllerian hormone as markers of gonadal function after treatment for medulloblastoma or posterior fossa ependymoma during childhood. J Pediatr. 2011; 158(6):1016–1022.e1. - PubMed
    1. von Bueren AO, von Hoff K, Pietsch T, et al. Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. Neuro Oncol. 2011; 13(6):669–679. - PMC - PubMed